Christèle Gonneau, PhD

Dr. Christèle Gonneau graduated with a BS in molecular biology from the Florida Institute of Technology (U.S.) and an MS in human reproductive biology from Imperial College London (U.K.). She then specialized in the field of stem cell biology and completed her PhD at the University of Edinburgh (U.K.) and her four years of postdoctoral training at the Ecole Polytechnique Fédérale de Lausanne (Switzerland).

Caitlyn Fritsche

Caitlyn Fritsche is a global manager who oversees the flow cytometry data analysis unit for Labcorp Central Laboratory Services. Caitlyn has 18 years of experience with Labcorp. In her current role, she supports the flow cytometry team by providing scientific leadership, technical guidance and troubleshooting. Since taking on her role as global manager, Caitlyn has successfully driven process optimization within her organization.

Anissa Fries, PhD

Dr. Anissa Fries joined Labcorp Drug Development in 2021 as a staff scientist in the flow cytometry department. In her role, Anissa is responsible for developing and validating new flow cytometry assays, as well as transferring validated assays into Labcorp’s central laboratory in Geneva.

Alexandre Fort, PhD

Dr. Alexandre Fort joined Labcorp Central Laboratory Services in 2017, bringing more than 15 years of fundamental and clinical genomics research experience. Alexandre has an extensive experience as a research scientist in the field of medical genetics, human genomics and transcriptomics. He is also an author of more than 20 peered-reviewed scientific publications and presentations.

Matthew Evans, PhD

Dr. Matthew Evans joined Labcorp Drug Development as part of the development and validation team in 2019. In his current role, Matt is the global scientific director of this team, which provides genomics clinical assays for our clients, including qPCR, arrays and next-generation sequencing. As the global scientific director, he provides scientific and technical leadership for the exploration and establishment of new platforms and tests to support cutting-edge clinical trials. 

Sian Estdale, PhD

Dr. Sian Estdale joined Labcorp in 2002 and is head of scientific affairs for Labcorp Central Laboratory Services, Bioanalytical Services and Biopharmaceutical Chemistry, Manufacturing and Control Services. She has more than 20 years of industry experience and more than 10 years of experience as a lecturer and researcher in biomedical sciences at Bradford and Sheffield Hallam universities. She is the author of more than 60 peer-reviewed papers and industry presentations.

Luna Dong

Luna Dong joined Labcorp Central Laboratory Services’ flow cytometry team in 2022. In her current role, Luna performs complex troubleshooting and problem-solving, supporting lab operations to ensure the smooth transition of assays into production. She participates in developing/identifying new strategies, techniques and instrumentation for developing new ventures in the scientific area of expertise for Labcorp Central Labs’ global laboratory operations.

Kerry Deutsch, PhD

Dr. Kerry Deutsch leads the specialty genomics bioinformatics team at Labcorp Drug Development. The team supports data analysis and pipeline development for both the production and research and development arms of the specialty genomics lab, working on a wide variety of assays from qPCR- and array-based platforms to a full spectrum of next-generation sequencing assays including whole-genome sequencing, whole-exome sequencing and targeted panels; whole, targeted and single-cell RNA sequencing; and ctDNA sequencing.

Xiaofei Cong, PhD

Dr. Xiaofei Cong joined Labcorp Central Laboratory Services’ immunology department in May 2021. As a scientist II based in Shanghai, he has led immunoassay validation, overseen collaborative scientific projects at Asia-Pacific sites and provided cross-departmental support to meet the clinical research needs of global clients.

Di Chen, PhD

Dr. Di Chen joined Labcorp Central Laboratory Services’ anatomic pathology team in 2020, bringing comprehensive knowledge in the fields of molecular pathology, genomics, biochemistry and oncology. He serves as a scientist within the anatomic pathology and histology (APH) group at Labcorp’s central lab, where he is responsible for developing and validating APH-related assays for use in clinical trials.